We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$155M
AUM Growth
+$4.64M
Cap. Flow
-$1.19M
Cap. Flow %
-0.77%
Top 10 Hldgs %
30.98%
Holding
150
New
9
Increased
28
Reduced
87
Closed
5

Top Buys

Rank Stock Value
1
BAY
BAYER AG SPONS ADR
BAY
+$651K
2
BIVV
Bioverativ Inc. Common Stock
BIVV
+$239K
3
COR icon
Cencora
COR
+$225K
4
AABA
Altaba Inc
AABA
+$213K
5
QVAL icon
Alpha Architect US Quantitative Value ETF
QVAL
+$199K

Top Sells

Rank Stock Value
1
VPL icon
Vanguard FTSE Pacific ETF
VPL
+$291K
2
PDCO
Patterson Companies, Inc.
PDCO
+$285K
3
USCI icon
US Commodity Index
USCI
+$277K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$260K
5
PNRA
Panera Bread Co
PNRA
+$220K

Sector Composition

Rank Sector Weight
1 Healthcare 22.78%
2 Financials 12.26%
3 Technology 11.93%
4 Industrials 10.01%
5 Consumer Staples 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
META icon
101
Meta Platforms (Facebook)
META
$1.39T
$335K 0.22%
1,959
– –
CMCSA icon
102
Comcast
CMCSA
$85.3B
$332K 0.21%
8,634
-600
-6% -$23.6K
TGT icon
103
Target
TGT
$65.4B
$330K 0.21%
5,584
-171
-3% -$9.58K
CHD icon
104
Church & Dwight Co
CHD
$23.4B
$329K 0.21%
6,794
-50
-0.7% -$2.54K
BCR
105
DELISTED
CR Bard Inc.
BCR
$327K 0.21%
1,021
-50
-5% -$16K
LOW icon
106
Lowe's Companies
LOW
$117B
$322K 0.21%
4,030
-1,240
-24% -$94.9K
APH icon
107
Amphenol
APH
$198B
$313K 0.2%
14,800
– –
BLK icon
108
Blackrock
BLK
$170B
$308K 0.2%
689
– –
MRK icon
109
Merck
MRK
$323B
$307K 0.2%
5,026
-182
-3% -$11K
WIA
110
Western Asset Inflation-Linked Income Fund
WIA
$184M
$287K 0.19%
24,848
-1,963
-7% -$22.5K
IBM icon
111
IBM
IBM
$207B
$285K 0.18%
2,055
-21
-1% -$2.93K
DE icon
112
Deere & Co
DE
$161B
$283K 0.18%
2,250
-105
-4% -$13K
SJM icon
113
J.M. Smucker
SJM
$12.9B
$281K 0.18%
2,678
+170
+7% +$19.4K
DCI icon
114
Donaldson
DCI
$10.9B
$280K 0.18%
6,086
-175
-3% -$8.1K
WAB icon
115
Wabtec
WAB
$49.5B
$276K 0.18%
3,650
-245
-6% -$18.9K
PAYX icon
116
Paychex
PAYX
$41.5B
$261K 0.17%
4,355
– –
AB icon
117
AllianceBernstein
AB
$3.43B
$257K 0.17%
10,571
-1,050
-9% -$25.3K
SLB icon
118
SLB Ltd
SLB
$72.9B
$255K 0.16%
3,657
– –
RDS.A
119
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$254K 0.16%
4,200
– –
VCSH icon
120
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$240K 0.16%
3,000
– –
WLY icon
121
John Wiley & Sons Class A
WLY
$2.61B
$240K 0.16%
4,495
-125
-3% -$6.71K
CHL
122
DELISTED
China Mobile Limited
CHL
$240K 0.16%
4,750
+75
+2% +$4K
OPPJ
123
WisdomTree Trust WisdomTree Japan Opportunities Fund
OPPJ
$275M
$236K 0.15%
11,050
– –
DCM
124
DELISTED
NTT DOCOMO, Inc.
DCM
$235K 0.15%
10,310
-650
-6% -$15.1K
BIVV
125
DELISTED
Bioverativ Inc. Common Stock
BIVV
$232K 0.15%
+4,073
New +$239K
2 3 4
5
6

Similar funds

VBFP
Valtinson Bruner Financial Planning New Brighton, Minnesota $364M AUM 9.63% 1-Year Est. Return
EW
Evexia Wealth Stevens Point, Wisconsin $364M AUM 29.61% 1-Year Est. Return
RBFC
Roman Butler Fullerton & Co St Louis, Missouri $364M AUM 27.64% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $365M AUM
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return
SWA
Strata Wealth Advisors Dallas, Texas $365M AUM 16.8% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Roberts, Glore & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Roberts, Glore & Co held 150 positions worth $155M, up 3.1% from $150M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Roberts, Glore & Co's Q3 2017 filing shows 9 new, 28 increased, 87 reduced and 5 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 4,073 shares worth $232K. The largest sale was Vanguard FTSE Pacific ETF, an estimated $291K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Financials and Technology.

  • Roberts, Glore & Co's largest Q3 2017 buy was Bioverativ Inc. Common Stock: 4,073 shares worth $232K.
  • Roberts, Glore & Co added most to BAYER AG SPONS ADR in Q3 2017, an estimated $651K increase.
  • Roberts, Glore & Co's biggest Q3 2017 reduction was Vanguard FTSE Pacific ETF, cutting an estimated $291K.
  • Roberts, Glore & Co fully exited Patterson Companies, Inc. in Q3 2017, selling an estimated $285K.
  • Roberts, Glore & Co's ten largest holdings make up 31% of its $155M portfolio in Q3 2017.
  • Roberts, Glore & Co opened 9 new positions and closed 5 in Q3 2017.
  • Roberts, Glore & Co's portfolio value rose 3.1% quarter-over-quarter to $155M.

Based on Roberts, Glore & Co's 13F filing for Q3 2017, filed 8 Nov 2017.